FLT201 Gene Therapy Shows Promise in Gaucher Disease Trial
Spur Therapeutics released positive Phase 1/2 trial data for FLT201, a gene therapy for Gaucher disease type 1. The...
SiteOne Announces Positive Phase 1 Data for Novel Non-Opioid Pain Drug
SiteOne Therapeutics announced positive Phase 1 clinical trial results for STC-004, its lead NaV1.8 inhibitor for non-opioid pain treatment....
Aclaris Announces Fully Funded Clarity Trial for Nociscan
Aclarion, Inc. (Nasdaq: ACON, ACONW) has secured approximately $20 million to fully fund its pivotal CLARITY trial. This trial...
CD47 Inhibitor Drugs Market 2028: 100+ Clinical Trials & Opportunities
The report “Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028” explores the burgeoning field of...
Nexalin’s Breakthrough DIFS™ Device Reduces Blood Pressure, Improves Mental Health
Nexalin Technology, Inc. announced positive results from a clinical study published in the Journal of Affective Disorders, showing its...
Tenaya Therapeutics Gets $8M Grant for Heart Failure Research
Tenaya Therapeutics received an $8 million grant from the California Institute for Regenerative Medicine (CIRM) to fund its Phase...
Seclidemstat and Azacitidine Trial for Hematologic Cancers Patient Enrollment Resumes
Salarius Pharmaceuticals (Nasdaq: SLRX) has announced the resumption of patient enrollment in a Phase 1/2 clinical trial at MD...
GH001 Meets Primary Endpoint in Phase 2b TRD Trial
GH Research PLC announced positive Phase 2b trial results for GH001, an inhalable mebufotenin treatment for treatment-resistant depression (TRD)....
Invivyd Announces Positive Phase 1/2 Data for VYD2311 for COVID-19
Invivyd announced positive Phase 1/2 clinical trial data for VYD2311, a monoclonal antibody designed to offer superior, long-lasting protection...
Eyonis™ Lung Cancer Screening Meets Primary Endpoint in RELIVE Trial
Median Technologies announced positive top-line results from its RELIVE study for eyonis™ LCS, an AI-powered lung cancer screening software....